Charite, Universitaetsmedizin Berlin, Campus Virchow-Klinikum

Berlin D-13353

0 studies enrolling now · 6 studies all time

What they study most

Coronary Artery Disease, Crohn's Disease, Endometrial Neoplasms, Follicular Lymphoma, Lymphoma, Non-Hodgkin

Studies at this site

• Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) — Completed
• A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer — Completed
• A Study To Monitor Long-Term Treatment With PF-00547659 — Completed
• A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) — Completed
• The Safety And Efficacy Of Maintenance Therapy With CP-690,550 — Completed
• SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries — Status unconfirmed